Francesco Giammarile

Also affiliated with International Atomic Energy Agency

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Radiotherapy and theranostics: a Lancet Oncology Commission”.

Radiotherapy and theranostics: a Lancet Oncology Commission

The Lancet Oncology(2024)10.1016/s1470-2045(24)00407-8

N/A

0DataRank · unranked

125 citations

Francesco Giammarile, M. Carrara, Diana Páez, Hedvig Hricak, Nayyereh Ayati +47 more

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology

The Lancet Oncology(2024)10.1016/s1470-2045(24)00030-5

N/A

0DataRank · unranked

72 citations

Peter J. H. Scott, Andrew M. Scott, Albert D. Windhorst, Brian M. Zeglis, May Abdel–Wahab +14 more

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics

The Lancet Oncology(2024)10.1016/s1470-2045(24)00037-8

N/A

0DataRank · unranked

62 citations

Brian M. Zeglis, Suzanne E. Lapi, Peter J. H. Scott, Albert D. Windhorst, May Abdel–Wahab +13 more

Production and regulatory issues for theranostics

The Lancet Oncology(2024)10.1016/s1470-2045(24)00041-x

N/A

0DataRank · unranked

54 citations

Diana Páez, Richard Zimmermann, Cathy S. Cutler, Amir Reza Jalilian, Aruna Korde +12 more

Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities

The Lancet Oncology(2024)10.1016/s1470-2045(24)00038-x

N/A

0DataRank · unranked

23 citations

C. Norman Coleman, Jesper Grau Eriksen, Peter Lee, Ryan Kraus, Ekaterina Harsdorf +24 more